BioSpace News Archive

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), today announced it has received approval from the Spanish Agency for Medicines and Health Products (AEMPS) Competent Authority and from the CElm Provincial de Sevilla Ethics Committee in Spain for the Company’s potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.

Conavi Medical Inc. and Sunnybrook Health Sciences Centre, announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.

Zymeworks Inc. today announced that it has completed enrollment in its global HERIZON-BTC-01 pivotal clinical trial evaluating the antitumor activity of zanidatamab monotherapy.

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced it will host a conference call on May 10, 2022, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2022.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Prisma Health, South Carolina’s largest non-profit healthcare system, today announced they have entered into a multi-year agreement to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance.

Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians, and payers seeking more choices without compromising excellent outcomes.

Pluristyx, Inc., an advanced therapy tools and services biotechnology company, and Accelerated Biosciences, a regenerative medicine innovator in the use of proprietary human trophoblast stem cells (hTSCs), today announced they signed an agreement for Pluristyx to manufacture clinical grade hTSC banks under Good Manufacturing Practices (GMP).

Turner Innovations (Turner), a company focused on research and development of advanced X-ray imaging technologies, announced today it was awarded an Air Force SBIR Phase II contract of $749,872.

Nortech Systems Incorporated (Nasdaq: NSYS), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, will hold a live conference call and webcast at 4:00 p.m. central time on Wednesday, May 11, 2022, to discuss the company’s first quarter financial results.

According to Report, the global bone grafts and substitutes market was estimated at USD 2.80 billion in 2020, and is predicted to surpass around USD 3.96 billion by 2030 with a CAGR of 6.1% from 2022 to 2030.